Ketamine-assisted therapy pairs small, carefully measured doses of ketamine with talk therapy to help people recover from alcohol or opioid addiction—and the depression that so often comes with it. It does something most medications don't: it works on the part of the brain tied to learning and habit, and the research shows it can quiet cravings and help people stay sober longer. At Wish Recovery, a luxury addiction treatment center in Los Angeles, ketamine therapy is part of a full program—medical detox, individual and group therapy, trauma work—with clinical support available around the clock and a treatment plan built around each person specifically.
I've heard this works when other treatments haven't—is that actually true?
Here's what's worth knowing before anything else: the skepticism is reasonable. If you're coming to this after things that didn't work, or didn't work for long, a healthy dose of doubt is part of thinking carefully. That deserves to be said before any data gets laid out.
The clinical picture for ketamine therapy and addiction is genuinely promising—and it's been building for years. A 2018 systematic review found improved abstinence rates across multiple substance types, including alcohol, opioids, and cocaine, with effects observed for up to two years following a single infusion (Jones et al., 2018). The researchers pointed to a specific feature of the brain's chemistry—the glutamate system—as the common thread across these substances, and ketamine targets that system directly.
A separate randomized pilot trial published in the American Journal of Psychiatry took that a step further, looking specifically at people with alcohol use disorder. Those who received a single ketamine infusion alongside motivational enhancement therapy—a structured, goal-focused therapy that helps people clarify why change matters to them—had significantly better odds of staying alcohol-free over the three weeks that followed, compared to those who received only a control treatment (Dakwar et al., 2020). One of the more clinically significant details in that study: ketamine appeared to reduce what researchers call the abstinence violation response. That's the collapse that can follow a single slip—when one drink stops feeling like a setback and starts feeling like proof that it was never going to work anyway. Reducing that spiral is meaningful.
None of this is a guarantee. The research is real and it's worth taking seriously, but it isn't a cure. What it points toward is an effective treatment option that reaches something conventional ketamine addiction treatment approaches often can't—particularly for people who've tried other paths and found them incomplete.
What is ketamine actually doing inside my brain that regular treatment couldn't reach?
Most psychiatric medications—antidepressants, mood stabilizers—work on the brain's serotonin or dopamine systems. Ketamine works differently. It's a dissociative anesthetic compound used at subanesthetic doses in clinical treatment—meaning the amount administered is carefully calibrated to be therapeutic rather than sedating—and it acts on the glutamate system, a communication network in the brain deeply involved in learning, memory, and habit formation.
In people with alcohol, opioid, or other substance use disorders, the part of the brain that handles impulse control and decision-making—along with the part that manages fear and emotional memory—can get stuck in patterns that keep feeding the cycle of craving and relapse (Jones et al., 2018). Those same brain regions are involved in depression and PTSD, too. That overlap is why treating addiction and mental health together tends to work better than treating them one at a time. Most medications don't reach these areas at all.
What makes ketamine stand out is what it does to the brain's ability to change. Neuroplasticity is the word researchers use for the brain's capacity to build new pathways—essentially, to learn and rewire itself. A clinical study found that within 24 hours of a single ketamine session, the brain showed measurable new growth in exactly the regions linked to emotional regulation and self-control, and those changes were connected directly to how well people responded to treatment (Kopelman et al., 2023). A separate review described this as the brain literally building new connections in the areas most damaged by long-term substance use—and called it an opening for real, lasting change (Muscat et al., 2022).
This matters for a reason that rarely gets named in the clinical literature: the shame of relapse often gets located in the person—their willpower, their character, their commitment. What the neuroscience is showing is that something real was happening in the brain's circuitry, and that circuitry can change. That's a different conversation than the one a lot of people have been having with themselves for years.
The neuroplasticity window—the 24 to 72 hours after a session when the brain is most structurally receptive to new learning—is where this potential either gets developed or gets missed. More on that shortly.
That window of neuroplasticity is one of the most important parts of what makes this work — and in a residential setting, we're able to make the most of every hour of it.
Reach out to learn how we structure care around that window.
My depression and my drinking feel like the same problem—can this actually treat both?
If you've wondered whether the alcohol came first or the depression, you've already touched something that clinical researchers have been trying to understand for decades. The honest answer is that for many people, these two conditions are biologically intertwined in ways that make treating one while ignoring the other consistently less effective (Ware, 2024). Treatment for depression and treatment for addiction share overlapping neurobiology—which is part of why a single approach that addresses both together tends to outperform two separate tracks.
A 2024 study looked at more than 130 facilities across the country that offer ketamine therapy and found that nearly two-thirds had started treating addiction and mental health at the same time—because the research kept showing that doing them separately didn't work as well (Ware, 2024). That's not a fringe opinion. It's become standard clinical thinking because the data pointed that way.
And when you look specifically at ketamine and alcohol use disorder, the numbers are striking. A review of eleven studies covering more than 850 people found that the best results—both for staying sober and for cutting back on drinking—came from programs that combined ketamine with structured therapy. Some early studies showed abstinence rates above 60%. For context, the most effective treatments at that time were capping out around 33% (Kelson et al., 2023).
There's something worth sitting with in that number. Sixty percent isn't perfect. But for someone who's felt like the depression and the drinking are one unbreakable loop—I'm drinking because I'm depressed, I'm depressed because I'm drinking—a treatment that addresses both simultaneously, at a neurological level, is a different kind of offer.
At Wish Recovery, integrated dual diagnosis treatment isn't an add-on. With no more than 12 clients at a time, co-occurring conditions receive the individualized clinical attention they require—not a standardized protocol applied uniformly to every person who walks through the door.
Does it matter where I do this—or is one ketamine session the same as the next?
The short answer is that where and how ketamine therapy happens matters considerably, and the research is clear about why.
Researchers looked at 19 studies on what happens when you pair ketamine with therapy, and the pattern held across all of them: people did better when the sessions were surrounded by structured support than when they received ketamine on its own (Kew et al., 2023). The approach that kept working had three parts—preparation before the session, support during it, and intentional integration work in the 24 to 48 hours right after. That window after a session is when the brain is most open to change. It's also exactly what residential care is built to fill.
It's worth understanding what a visit to one of the many ketamine clinics in Los Angeles actually looks like. Ketamine treatment in Los Angeles spans a wide range—from standalone treatment facilities offering a single infusion visit to full residential programs designed around the entire recovery arc. At most clinics in Los Angeles, the model is transactional: you receive a ketamine infusion treatment, the session ends, and you go home. What happens in your nervous system over the next two days—when the brain is at its most receptive to new patterns—happens in whatever environment you return to, with whatever support or absence of support surrounds you. Ketamine treatment programs built around outpatient-only visits simply aren't equipped to provide what happens around the session—the integration, the clinical presence, the contained environment. Treatment in Los Angeles varies enormously in depth, and that variance is clinically meaningful.
Some of the earliest formal research on ketamine's effectiveness for alcohol use disorder was conducted with populations who had completed three months of residential inpatient treatment before their ketamine infusions. The residential container was part of the clinical picture, and the abstinence outcomes at one- and two-year follow-up reflected that (Jones et al., 2018). The setting wasn't incidental to those results—it was part of the treatment approach itself.
In a luxury residential program like ours, the neuroplasticity window that opens after each session doesn't close around silence and uncertainty. Your clinical team is present. Therapeutic integration happens with the people who know your history and your goals. And the environment itself—private, calm, carefully designed for nervous system regulation—is part of what makes the therapy land.
When ketamine therapy happens inside a full residential program — not a standalone clinic — the support around it changes what's possible. See if your insurance covers care in our residential setting.
What happens between the ketamine sessions—is that where the real work actually happens?
Yes. The therapy that surrounds the ketamine sessions—before, during, and after each one—is where the lasting changes get made.
When researchers looked at what kinds of therapy tended to work alongside ketamine, the same names kept coming up: CBT, motivational enhancement therapy, mindfulness-based relapse prevention (MBRP), and supportive group therapy (Kew et al., 2023). MBRP in particular stood out across multiple studies—because it's built specifically to target cravings and the emotional states that tend to push people toward relapse.
CBT—cognitive behavioral therapy—is an approach that helps people identify and shift the thought patterns connected to compulsive behavior. DBT, or dialectical behavior therapy, builds skills for managing intense emotions and navigating relationships without reaching for a substance to cope. EMDR (eye movement desensitization and reprocessing) is a therapy designed to help the brain process traumatic memories without requiring someone to talk through them in detail—often powerfully relevant for people whose substance use is connected to trauma they haven't been able to touch yet. MBRP integrates mindfulness practices with CBT-based relapse prevention, training the brain to pause between a craving and a response.
Research published in Psychology of Addictive Behaviors found that MBRP itself produces changes in the brain regions associated with craving and negative affect—regions that addiction directly impacts—and suggested that MBRP may begin to repair some of the neurological changes that prolonged substance use creates (Witkiewitz et al., 2013). When ketamine opens the neuroplasticity window, these therapies have a more receptive brain to work with.
Each person's personalized treatment plan at Wish Recovery reflects this research. CBT, DBT, EMDR, trauma therapy, yoga, meditation, acupuncture, and mindfulness practices surround the ketamine sessions within a compassionate, supportive environment designed for the whole person. Wellness isn't a brochure word here—it's the clinical architecture. The clinical and the restorative work together because the evidence says they should.
Am I just trading one thing for another—and how do I know this is actually safe for me?
This concern gets asked quietly, if at all. But we hear it, and we understand why.
The fear of substituting one substance for another shows that you're thinking carefully about this—that you're not just reaching for the next thing because it sounds new. That kind of discernment is worth honoring before any clinical information is offered.
Here's what the evidence shows about how supervised ketamine therapy works. The doses used in ketamine-assisted psychotherapy are considerably lower than what's typically associated with the misuse of ketamine recreationally. Symptoms of ketamine addiction—including tolerance, compulsive use, and ketamine withdrawal symptoms like mood changes and cravings after stopping long-term ketamine use—are associated with high doses used repeatedly outside clinical oversight. People coming to ketamine rehab specifically to address a substance use or mental health condition—not recreational use—are in a fundamentally different clinical context.
Addressing ketamine addiction or any co-occurring mental health issues through a structured program also means that detox for ketamine addiction, when needed, happens within 24/7 medical supervision before therapeutic work begins. The protocol in a clinical rehab setting is built around what happens during and after each session, not just the infusion itself. When researchers looked at close to a thousand people being treated for alcohol use disorder, the programs that produced the best outcomes were the ones where ketamine was paired with therapy—used as a door-opener, not handed over alone (Kelson et al., 2023).
A 2025 clinical trial designed for publicly insured patients receiving ketamine-assisted therapy built in careful monitoring at every stage—tracking physical responses during dosing and pairing each session with behavioral therapy—because the researchers understood that what surrounds the ketamine is what determines whether it helps or harms (Mehtani et al., 2025). That kind of built-in structure is what makes a clinical program different from anything else being offered.
At Wish Recovery, ketamine-assisted therapy takes place within 24/7 medical oversight. Every session is conducted by licensed clinical staff with continuous monitoring before, during, and after. For professionals, executives, and high-profile individuals who need to know that their privacy is protected throughout, our HIPAA-compliant, confidential environment is designed for exactly that kind of trust.
Your concern about safety is the right instinct. The protocol is built with that concern at the center.
If safety is the thing keeping you from taking the next step, we want you to have the full picture — our medical team is here around the clock, and nothing happens without careful clinical oversight.
Reach out and ask us anything.
Why does the luxury residential setting actually change what becomes possible here?
The physical and clinical environment surrounding ketamine therapy shapes what the therapy can accomplish. This connection shows up directly in the research.
The neuroplasticity that ketamine initiates—specifically, the growth of new synaptic connections in the prefrontal cortex and limbic system—is most active in the 24 to 48 hours following a session, and that growth requires a stable, therapeutically supported environment to develop into lasting change (Muscat et al., 2022). An environment that's noisy, unpredictable, emotionally activating, or simply uncontained works against that process at a neurological level.
There's also a clinical consideration specific to the population that often seeks luxury residential care. People who've been high-functioning while struggling—executives, healthcare professionals, artists, parents—tend to carry a particular clinical profile: conditions that haven't responded fully to previous treatment, high-stress histories, and a need for privacy that most standard facilities genuinely can't accommodate. Research on ketamine's rapid effects on depression has noted that people with developmental trauma often have a reduced capacity to build the therapeutic trust required for standard extended treatment schedules—and that ketamine's rapid action may offer a way in where other approaches have stalled (Muscat et al., 2022).
At Wish Recovery, our luxury residential treatment center isn't about comfort as an end in itself. It's about what the environment makes clinically possible. Twelve clients at a time means each person's neuroplasticity window gets real clinical attention—a team that has the capacity to be present during the hours when the brain is most open to therapeutic work. Private suites and gardens aren't amenities added to a program; they're the sensory conditions that support nervous system regulation between sessions. For working professionals who need to maintain some business or academic responsibilities during treatment, our Professionals Program offers the structure to do that without sacrificing the depth of clinical care.
What sets specialized ketamine treatment within a full residential setting apart from other treatment programs in Los Angeles is the comprehensive ketamine addiction treatment framework built around each session—personalized treatment that accounts for your history, your co-occurring conditions, and your nervous system. Our treatment services don't start when you arrive for a session and end when you leave. They surround the therapy in Los Angeles and well beyond it. From medical detox through residential treatment and into our intensive outpatient program (IOP), the continuum of care is designed so that what opens during residential treatment doesn't close at discharge. The neuroplastic gains you make here have somewhere to go.
If this works—what does the rest of my recovery actually look like from here?
Ketamine-assisted therapy creates an opening. What happens inside that opening—and in the months that follow—determines how durable the change becomes. Lasting recovery doesn't end at discharge; it's built through the treatment process that comes after.
One study looked at what happened when people received multiple ketamine sessions versus just one, and the difference was real: roughly half of those in the multiple-session group stayed heroin-free at one year, compared to about one in five in the single-session group. More ketamine wasn't what made the difference. It was the therapy that surrounded each session—the work that helped people make sense of what the ketamine opened up (Kelson et al., 2023). One session can start something. Staying with it is what makes it last.
The pattern held across multiple studies: people who kept working with a therapist after their ketamine sessions ended did better than those who didn't (Kew et al., 2023). Recovery doesn't hold on its own. It needs something to step into—some kind of structure that keeps going when residential care ends. That's what programs built around a full continuum of care are there for.
At Wish Recovery, the residential KAT program transitions into outpatient treatment through our intensive outpatient program (IOP)—the ongoing structure that keeps integration work moving after residential. For people evaluating ketamine addiction treatment options in Los Angeles, the distinction between a program that ends at discharge and one that carries you forward is clinically significant. Ketamine addiction treatment in Los Angeles varies widely in depth; personalized ketamine addiction treatment—where the plan adapts to your progress, your co-occurring conditions, and your life outside treatment—is what makes the difference between short-term results and lasting ones. Addiction treatment in Los Angeles rarely comes with this level of continuity. Mental health recovery and addiction recovery aren't separate tracks here. You don't have to be in a residential setting forever for the neuroplastic gains to hold. But you do benefit from a clinical system that carries you forward—that treats discharge as a handoff, not a finish line.
You don't have to have the full recovery picture mapped before you take the first step. You just need enough structure around you to keep learning what your brain has become newly able to learn.
You don't have to have all the answers tonight to take the next step
Something brought you here. You read this far, which means something shifted—even if you're not ready to name it yet. That shift is enough. We work with a small number of people at a time, in a private setting, with a team that has the space to actually know you. That's not a marketing promise. It's the structure we built so that real care is possible.
When you're ready to talk—not commit, just talk—we're here, confidentially, anytime.
You don't have to have everything figured out to reach out—that's what this first conversation is for. Check your insurance and take the first step when you're ready.
Frequently asked questions
Does ketamine therapy actually work for addiction treatment?
Yes—clinical research supports effective ketamine addiction treatment for alcohol, opioid, and cocaine use disorders, particularly when it's paired with structured therapy. Some studies have tracked people for two years after treatment and found that the benefits held. People who stay in a program with ongoing therapy after their sessions tend to hold onto those gains much longer. Ketamine treatment centers that assist clients through the full neuroplasticity window—not just the infusion itself—consistently show stronger outcomes than those offering ketamine infusion treatment alone.
Is ketamine therapy safe if I have a history of substance use?
It's a fair question, and the honest answer is: it depends entirely on the setting. In a supervised clinical program with carefully controlled doses, ketamine therapy has a very different risk profile than recreational use. Reputable ketamine treatment centers screen thoroughly before anyone begins, monitor clients around the clock, and build structured therapy into the program from the start—specifically to reduce the risk of dependency. Whether it's the right fit is something that gets determined through a full clinical assessment, one-on-one. For people who are also dealing with depression or other mental health conditions alongside addiction, a good evaluation looks at the full picture—including other options like transcranial magnetic stimulation (TMS), which uses gentle magnetic pulses to stimulate specific areas of the brain, as well as other treatment services for addiction and treatment for depression. Most people find that a residential program, where support is available around the clock, is the safest and most effective place to do this work.
How is ketamine-assisted therapy different in a residential program versus a standalone clinic?
In a residential program, ketamine sessions are embedded within a full therapeutic structure—including preparatory therapy, real-time integration support, and 24/7 clinical care in the 24 to 72 hours after each session, when the brain is most neurologically receptive to therapeutic change. A standalone clinic visit cannot replicate this level of continuous clinical support. For people weighing their options, this distinction—what surrounds the session, not just the session itself—is what separates effective ketamine addiction treatment from a procedure.
References
- Jones, J., Mateus, C. F., & Malcolm, R. (2018). Efficacy of ketamine in the treatment of substance use disorders: A systematic review. Frontiers in Psychiatry, 9, 277. https://doi.org/10.3389/fpsyt.2018.00277
- Dakwar, E., Levin, F. R., & Hart, C. L. (2020). A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled pilot trial. American Journal of Psychiatry, 177(2), 125–133. https://doi.org/10.1176/appi.ajp.2019.19070684
- Kopelman, J. M., Keller, T. A., & Panny, B. (2023). Rapid neuroplasticity changes and response to intravenous ketamine: A randomized controlled trial in treatment-resistant depression. Translational Psychiatry, 13(1). https://doi.org/10.1038/s41398-023-02451-0
- Muscat, S. A., Hartelius, G., & Crouch, C. (2022). Optimized clinical strategies for treatment-resistant depression: Integrating ketamine protocols with trauma- and attachment-informed psychotherapy. Psych, 4(1), 119–141. https://doi.org/10.3390/psych4010012
- Kelson, M., Burnett, J. M., & Matthews, A. (2023). Ketamine treatment for alcohol use disorder: A systematic review. Cureus. https://doi.org/10.7759/cureus.38498
- Ware, O. D. (2024). Mental health facilities with ketamine infusion therapy in the United States in 2020: Co-location of dual diagnosis mental health and substance use disorder treatment. Experimental and Clinical Psychopharmacology, 32(3), 263–269. https://doi.org/10.1037/pha0000686
- Kew, B. M., Porter, R., & Douglas, K. M. (2023). Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review. BJPsych Open, 9(3). https://doi.org/10.1192/bjo.2023.53
- Witkiewitz, K., Lustyk, M. K. B., & Bowen, S. (2013). Retraining the addicted brain: A review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention. Psychology of Addictive Behaviors, 27(2), 351–365. https://doi.org/10.1037/a0029258
- Mehtani, N. J., Anderson, B., & Alexander, I. (2025). Ketamine-Assisted Recovery (KARE): Protocol for an open-label pilot trial of ketamine-assisted psychotherapy for publicly insured patients with methamphetamine use disorder and HIV risks. BMJ Open, 15(8), e100775. https://doi.org/10.1136/bmjopen-2025-100775
June 08, 2026
